Inventor

SYLVIE GARNEAU-TSODIKOVA

Inventor

Overview

4→

Patents

2022–2024

Patent span

Human necessities

Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%

A01NPreservation of bodies of humans or animals or plants or parts thereof20%

C07CAcyclic or carbocyclic compounds20%

C07DHeterocyclic compounds20%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium10%

PatentTitleYear

12,103,916Antifungal compounds2024 11,851,391Antifungal compounds and methods of forming the same2023 11,564,394Distorted gold (I)-phosphine complexes and and methods for use as antifungal agents2023 11,535,592Antimicrobial compounds, compositions, and method2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to UNIV KENTUCKY RES FOUND (4)· patent assignee history

2022–2024Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV KENTUCKY RES FOUND	4	2022–2024

Locations

Location	Patents	Span
US	4	2022–2024